This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. Kirk Martin, Jr, MD; Robert W. Beart, Jr, MD; Peter Mucha, Jr, MD; H. Clark Hoagland, MD

Arch Surg. 1983;118(10):1224-1226.

Abstract
• Between July 1980 and May 1981, 32 permanent indwelling Hickman catheters were implanted in 29 patients. Most of the catheters were placed for treatment of acute leukemia (25 patients) or lymphoma (two patients). Catheters were used for a total of 3,461 patient-days (mean, 108 days). Two patients had infections at the exit site, one seven and the other 11 days after implantation. Four patients had sepsis, but none of those infections appeared to be catheter related. Hickman catheters appear to provide ease of treatment in acute leukemia and are associated with patient satisfaction and an acceptable complication rate.

(Arch Surg 1983;118:1224-1226)

Author Affiliations
From the Department of Surgery (Drs Martin, Beart, and Mucha) and the Division of Hematology and Internal Medicine (Dr Hoagland), Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Accepted for publication April 7, 1983.

Reprint requests to Department of Surgery, Mayo Clinic, Rochester, MN 55905 (Dr Martin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reliability of Implantable Central Venous Access Devices in Patients With Cancer
Stanislav et al.
Arch Surg 1987;122:1280-1283.
ABSTRACT  

Complication of a Hickman Catheter: Cutaneous Erosion of the Dacron Cuff
Fisher
JAMA 1985;254:2934-2934.
ABSTRACT